Font Size: a A A
Keyword [Human Epidermal Growth Factor Receptor-2]
Result: 41 - 60 | Page: 3 of 4
41. HER2 Positive Bilateral Metachronous Primary Breast Carcinoma: A Case Report And Literature Review
42. Expression And Clinical Significance Of CEACAM-6 And MMP-9 In Breast Cancers
43. The Analysis Of Diagnosis And Treatment In HER2 Positive Breast Cancer
44. Application Value Of Stretched Exponential DWI In Breast Lesions
45. Analysis Of Efficacy Of First-line Treatment For Advanced Breast Cancer Patients With Hormone Receptor Positive And Human Epidermal Growth Factor Receptor 2 Negative
46. Correlation Between Positive HER-2 Breast Cancer Stem Cells And Drug Resistance Of Breast Cancer MDA-MB-468 Cells
47. The Research Of Correlation Between The HER2 Expression And The Clinicopathological Characteristics And Prognosis Of Early Breast Cancer Patients Undergoing Trastuzumab-containing Therapy
48. Application Of Magnetic Resonance Nanoparticles In HER-2 Positive Breast Cancer
49. Efficacy And Prognosis Of Trastuzumab With Or After Neoadjuvant Chemotherapy For HER2-positive Breast Cancer
50. HER2 Protein Expression Correlates With Lauren Classification And P53 In Gastric Cancer Patients
51. Efficacy Of Paclitaxel And Albumin-bound Paclitaxel In Neoadjuvant Chemotherapy For Human Epidermal Growth Factor Receptor-2(HER2)Negative Breast Cancer
52. Human/rat HER2-specific Exosome-targeted T Cell Vaccine For HER2~+ Breast Cancer Immunotherapy
53. Clinical Analysis Of Lapatinib In Combination With Capecitabine Versus Continued Use Of Trastuzumab In Advanced HER2-positive Breast Cancer Patients With Trastuzumab-resistance
54. Expression And Clinical Significance Of MSI And PD-L1 In HER2-positive Gastric Cancer
55. Correlation Study On The Expression Of HER2 And Ki67 In Breast Cancer With Their Ultrasound Signs
56. High Expression Of HER-2 Is A Risk Factor For Poor Prognosis Of Colorectal Cancer
57. Prognostic Role Of Human Epidermal-growth-factor Receptor 2(HER-2) In Colorectal Cancer
58. Analysis Of Clinical Applicability Of Modified Residual Cancer Burden System In Evaluating The Pathological Response Of Breast Cancer After Neoadjuvant Treatment
59. Establishment Of Comprehensive Prognostic Models For Breast Cancer Based On LncRNA Expression Profiles
60. A Study On The Correlation Between The Pathological Features And Treatment And Prognosis Of HER-2 Positive Breast Cancer
  <<First  <Prev  Next>  Last>>  Jump to